• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[125I]生长激素在体内转化为高分子量形式。

Conversion of [125I]growth hormone into high molecular weight forms in vivo.

作者信息

Antoniades H N

出版信息

Endocrinology. 1975 Mar;96(3):799-802. doi: 10.1210/endo-96-3-799.

DOI:10.1210/endo-96-3-799
PMID:1116486
Abstract

[125I]-growth hormone, injected in rats, was converted into high molecular weight forms (70,000 to over 200,000 daltons) as judged by gel filtration of blood serum samples collected after the injection. These forms were reactive with antisera against growth hormone, although their immunoreactivity was only 50% of that of control, single component [125I]growth hormone. Their molecular weight was not affected significantly by denaturation with sodium dodecyl sulfate. Incubation of [125I]growth hormone with blood serum in vitro did not result in the production of high molecular weight forms.

摘要

给大鼠注射[125I]生长激素后,通过对注射后采集的血清样本进行凝胶过滤判断,其转化为了高分子量形式(70,000至超过200,000道尔顿)。这些形式与抗生长激素抗血清有反应,尽管它们的免疫反应性仅为对照单一组分[125I]生长激素的50%。它们的分子量不受十二烷基硫酸钠变性的显著影响。在体外将[125I]生长激素与血清一起孵育不会产生高分子量形式。

相似文献

1
Conversion of [125I]growth hormone into high molecular weight forms in vivo.[125I]生长激素在体内转化为高分子量形式。
Endocrinology. 1975 Mar;96(3):799-802. doi: 10.1210/endo-96-3-799.
2
Conversion of (125I)insulin and (125I)proinsulin into high molecular weight forms in vivo.(125I)胰岛素和(125I)胰岛素原在体内转化为高分子量形式。
Endocrinology. 1974 Dec;95(6):1543-53. doi: 10.1210/endo-95-6-1543.
3
Guinea pig serum contains a specific high affinity growth hormone-binding protein with novel ligand specificity.豚鼠血清含有一种具有新型配体特异性的特异性高亲和力生长激素结合蛋白。
Endocrinology. 1997 Sep;138(9):3577-86. doi: 10.1210/endo.138.9.5374.
4
Characterization of a low affinity binding protein for growth hormone in rat serum.大鼠血清中生长激素低亲和力结合蛋白的特性研究
Endocrinology. 2000 Jan;141(1):138-45. doi: 10.1210/endo.141.1.7238.
5
Mechanism of tubular uptake on human growth hormone in perfused rat kidneys.
J Pharmacol Exp Ther. 1986 Mar;236(3):596-601.
6
In vivo conversion of peptide drugs into high molecular weight forms.肽类药物在体内转化为高分子量形式。
J Pharmacobiodyn. 1984 Dec;7(12):910-6. doi: 10.1248/bpb1978.7.910.
7
Size heterogeneity of rat pituitary prolactin.大鼠垂体催乳素的大小异质性
Biochem J. 1980 Sep 1;189(3):605-14. doi: 10.1042/bj1890605.
8
Metabolism of single-component and high-molecular-weight radioactive insulin in rats.大鼠体内单组分及高分子量放射性胰岛素的代谢
Endocrinology. 1976 Aug;99(2):481-9. doi: 10.1210/endo-99-2-481.
9
Existence of two forms of immunoreactive growth hormone in human plasma.人血浆中存在两种免疫反应性生长激素形式。
J Clin Endocrinol Metab. 1972 Dec;35(6):868-78. doi: 10.1210/jcem-35-6-868.
10
Heterogeneity of human growth hormone in serum.血清中人生长激素的异质性。
Ann Endocrinol (Paris). 1974 Sep-Oct;35(5):606-13.

引用本文的文献

1
Circulating growth hormone binding proteins.循环生长激素结合蛋白
J Endocrinol Invest. 1994 Jan;17(1):67-81. doi: 10.1007/BF03344965.
2
Binding of exogenous protein fragments to native proteins: possible explanation for the overestimation of uptake of extrinsically labelled macromolecules from the gut.外源蛋白片段与天然蛋白的结合:对肠道中外源标记大分子摄取量高估的可能解释。
Immunology. 1981 Feb;42(2):251-7.
3
Identification and characterization of specific binding proteins for growth hormone in normal human sera.正常人血清中生长激素特异性结合蛋白的鉴定与特性分析
J Clin Invest. 1986 Jun;77(6):1817-23. doi: 10.1172/JCI112507.